BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 32282038)

  • 1. The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19.
    McAteer J; Yildirim I; Chahroudi A
    Clin Infect Dis; 2020 Jul; 71(15):703-705. PubMed ID: 32282038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.
    COCONEL Group
    Lancet Infect Dis; 2020 Jul; 20(7):769-770. PubMed ID: 32445713
    [No Abstract]   [Full Text] [Related]  

  • 3. Even covid-19 can't kill the anti-vaccination movement.
    Megget K
    BMJ; 2020 Jun; 369():m2184. PubMed ID: 32499217
    [No Abstract]   [Full Text] [Related]  

  • 4. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Peeples L
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8218-8221. PubMed ID: 32229574
    [No Abstract]   [Full Text] [Related]  

  • 5. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 8. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19.
    Coish JM; MacNeil AJ
    Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning for a COVID-19 Vaccination Program.
    Schaffer DeRoo S; Pudalov NJ; Fu LY
    JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
    [No Abstract]   [Full Text] [Related]  

  • 11. Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.
    Graepel KW; Kochhar S; Clayton EW; Edwards KE
    J Infect Dis; 2020 Jun; 222(2):180-182. PubMed ID: 32365191
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 13. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.
    Tai W; Zhang X; Drelich A; Shi J; Hsu JC; Luchsinger L; Hillyer CD; Tseng CK; Jiang S; Du L
    Cell Res; 2020 Oct; 30(10):932-935. PubMed ID: 32759966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 17. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning for COVID-19 vaccines safety surveillance.
    Kochhar S; Salmon DA
    Vaccine; 2020 Sep; 38(40):6194-6198. PubMed ID: 32684499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.